CDC Study Confirms COVID Vaccine Benefits, Release Blocked
▼ Summary
– CDC scientists were blocked from publishing a study showing this season’s COVID-19 vaccine significantly reduced emergency visits and hospitalizations.
– The blockage was ordered by acting CDC director Jay Bhattacharya, who cited methodological concerns about the study’s design.
– The study had already passed the CDC’s standard scientific review and was scheduled for publication in a key agency report.
– Health experts warn that political interference under Health Secretary Robert F. Kennedy Jr. is undermining federal science.
– Agency scientists spoke anonymously to The Washington Post, fearing retaliation from the Trump administration.
A new study from the Centers for Disease Control and Prevention has found this season’s COVID-19 vaccine provides substantial protection, yet its release has been halted by agency leadership. The research, which underwent the CDC’s standard scientific review, was scheduled for publication in the agency’s flagship Morbidity and Mortality Weekly Report. However, acting director Jay Bhattacharya intervened to block its release, citing methodological concerns. This action has intensified fears among public health experts that political interference under Health Secretary Robert F. Kennedy Jr. is actively undermining scientific integrity at federal agencies.
Scientists within the agency, speaking anonymously due to fear of retaliation, confirmed the study was fully vetted and ready for dissemination. The analysis examined data from last fall and winter, concluding that vaccinated healthy adults saw their risk of needing emergency or urgent care drop by 50 percent. Furthermore, their risk of COVID-19-associated hospitalization was reduced by 55 percent compared to unvaccinated peers. These findings underscore the continued real-world effectiveness of the updated vaccines in preventing severe outcomes.
The specific objection raised by Bhattacharya centers on the study’s test-negative design, a widely accepted and standard methodology for evaluating vaccine performance. This observational approach compares individuals with similar symptoms and testing behaviors, classifying them as either positive cases or negative controls based on their test results. Researchers then analyze the vaccination status between these groups to determine vaccine effectiveness. The design is a cornerstone of epidemiological research and is routinely used by the CDC and global health authorities.
The decision to suppress these findings occurs within a broader context of turmoil. Health Secretary Kennedy, a longtime anti-vaccine activist who has repeatedly spread misinformation about COVID-19 shots, has created an environment where scientific publication appears subject to political whims. Blocking a rigorously reviewed report that confirms clear public health benefits represents a significant departure from normal agency operations and risks eroding public trust. It signals that evidence-based recommendations may be sidelined in favor of ideological agendas, potentially leaving both healthcare professionals and the public without critical data for making informed decisions.
(Source: Ars Technica)
